×
About 153 results

ALLMedicine™ Simple Partial Seizures Center

Research & Reviews  46 results

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
https://clinicaltrials.gov/ct2/show/NCT01140867

Jan 4th, 2022 - The object of this study is to assess the efficacy and safety of zonisamide as adjunctive therapy in patients with uncontrolled partial epilepsy. Subject takes zonisamide for 16 weeks (4 weeks-titration period, 8 weeks maintenance period). Dose ra...

Carbamazepine Toxicity
https://emedicine.medscape.com/article/813654-overview

Oct 15th, 2021 - Practice Essentials Carbamazepine is an antiepileptic drug widely used for treatment of simple partial seizures and complex partial seizures, trigeminal neuralgia, and bipolar affective disorder. Carbamazepine is also used as a treatment for posth...

Carbamazepine Toxicity
http://emedicine.medscape.com/article/813654-overview

Oct 15th, 2021 - Practice Essentials Carbamazepine is an antiepileptic drug widely used for treatment of simple partial seizures and complex partial seizures, trigeminal neuralgia, and bipolar affective disorder. Carbamazepine is also used as a treatment for posth...

Carbamazepine Toxicity
https://emedicine.medscape.com/article/813654-print

Oct 15th, 2021 - Practice Essentials Carbamazepine is an antiepileptic drug widely used for treatment of simple partial seizures and complex partial seizures, trigeminal neuralgia, and bipolar affective disorder. Carbamazepine is also used as a treatment for posth...

Carbamazepine Toxicity
https://emedicine.medscape.com/article/1011240-overview

Oct 15th, 2021 - Practice Essentials Carbamazepine is an antiepileptic drug widely used for treatment of simple partial seizures and complex partial seizures, trigeminal neuralgia, and bipolar affective disorder. Carbamazepine is also used as a treatment for posth...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  3 results

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
https://clinicaltrials.gov/ct2/show/NCT01140867

Jan 4th, 2022 - The object of this study is to assess the efficacy and safety of zonisamide as adjunctive therapy in patients with uncontrolled partial epilepsy. Subject takes zonisamide for 16 weeks (4 weeks-titration period, 8 weeks maintenance period). Dose ra...

The Pattern of Pediatric Seizures at Al-Arish Central Hospital - North Sinai
https://clinicaltrials.gov/ct2/show/NCT03374384

Nov 26th, 2019 - A seizure or convulsion is a paroxysmal, time-limited change in motor activity and/or behavior that results from abnormal electrical activity in the brain . The International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy...

Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
https://clinicaltrials.gov/ct2/show/NCT00216567

Feb 1st, 2011 - Benign rolandic epilepsy (BRE) is a common seizure disorder confined solely to children. The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brie...

see more →

News  10 results

Cenobamate Reduces the Frequency of Partial-Onset Seizures
https://www.mdedge.com/neurology/epilepsyresourcecenter/article/169570/epilepsy-seizures/cenobamate-reduces

Jul 5th, 2018 - LOS ANGELES—Adjunctive treatment with an investigational antiepileptic drug (AED) reduces the median frequency of partial-onset seizures, according to trial results presented at the 70th Annual Meeting of the American Academy of Neurology. “The re.

Next-Generation Sequencing Nabs Culprit in Brain Infection
https://www.medscape.com/viewarticle/826389

Jun 9th, 2014 - Next-generation DNA sequencing leapt convincingly from bench to bedside when clinicians used the new tool to identify treatable bacterial meningoencephalitis in a 14-year old boy with severe combined immunodeficiency, fever, headache, hydrocephalu...

Next-Generation Sequencing Nabs Culprit in Brain Infection
https://www.staging.medscape.com/viewarticle/826389

Jun 9th, 2014 - Next-generation DNA sequencing leapt convincingly from bench to bedside when clinicians used the new tool to identify treatable bacterial meningoencephalitis in a 14-year old boy with severe combined immunodeficiency, fever, headache, hydrocephalu...

Characterizing the Postictal Phase of Temporal Lobe Seizures
https://www.medscape.com/viewarticle/777718

Jan 30th, 2013 - This is the Medscape Neurology Minute. I am Dr. Alan Jacobs. Temporal lobe seizures can induce impairment of normal brain function, such as postictal loss of consciousness or cognitive dysfunction. Now, researchers from the Department of Biomechan...

A New Epilepsy Etiology
https://www.medscape.com/viewarticle/777407_1

Jan 15th, 2013 - Introduction Autoimmune epilepsy is a newly recognized treatable cause of uncontrolled seizures. A retrospective review of patients who presented with uncontrolled seizures to both the epilepsy and neuroimmunology clinics of the Mayo Clinic betwee...

see more →

Patient Education  1 results see all →